Page last updated: 2024-08-23

substance p and Flushing

substance p has been researched along with Flushing in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19906 (60.00)18.7374
1990's3 (30.00)18.2507
2000's1 (10.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brattström, A; Oehme, P; Starzev, VG; Stechmesser, G1
Camilleri, M; Homburger, HA; Klee, GG; O'Brien, MD; Pitot, HC; Rubin, J; Saslow, SB; von der Ohe, M1
Byrne, B; Clive, S; Jodrell, DI; MacLellan, A; Robson, L; Smyth, JF; Webb, DJ; Young, A1
Cho, K; England, BG; Gonin, J; Jackson, T; McLeod, MK; Vinik, AI1
Braunstein, G; Fajac, I; Frossard, N; Lacronique, J1
Aggestrup, S; Schaffalitzky De Muckadell, OB; Stentoft, P1
Brodin, E; Norheim, I; Oberg, K; Theodorsson-Norheim, E1
Edvinsson, L; Goadsby, PJ; Haber, PS1
Edvinsson, L; Ekman, R; Goadsby, PJ1
Balks, HJ; Conlon, JM; Creutzfeldt, W; Stöckmann, F1

Trials

2 trial(s) available for substance p and Flushing

ArticleYear
Octreotide inhibition of flushing and colonic motor dysfunction in carcinoid syndrome.
    The American journal of gastroenterology, 1997, Volume: 92, Issue:12

    Topics: Aged; Antineoplastic Agents, Hormonal; Calcitonin Gene-Related Peptide; Colon; Colonic Diseases; Diarrhea; Digestion; Double-Blind Method; Female; Flushing; Gastrointestinal Agents; Gastrointestinal Motility; Gastrointestinal Transit; Histamine; Humans; Intestine, Small; Male; Malignant Carcinoid Syndrome; Middle Aged; Motilin; Neuropeptide Y; Neuropeptides; Neurotensin; Octreotide; Peptide YY; Placebos; Serotonin Antagonists; Substance P; Vasoactive Intestinal Peptide

1997
Forearm blood flow and local responses to peptide vasodilators: a novel pharmacodynamic measure in the phase I trial of antagonist G, a neuropeptide growth factor antagonist.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2001, Volume: 7, Issue:10

    Topics: Adult; Aged; Antineoplastic Agents; Brachial Artery; Bradykinin; Dose-Response Relationship, Drug; Female; Flushing; Forearm; Humans; Infusion Pumps; Male; Metabolic Clearance Rate; Middle Aged; Neoplasms; Neuropeptides; Oligopeptides; Regional Blood Flow; Substance P; Treatment Outcome; Vasodilator Agents

2001

Other Studies

8 other study(ies) available for substance p and Flushing

ArticleYear
[Long-term effects of substance P on the higher nervous activity of primates].
    Biomedica biochimica acta, 1984, Volume: 43, Issue:11

    Topics: Animals; Behavior, Animal; Blood Pressure; Conditioning, Classical; Dose-Response Relationship, Drug; Female; Flushing; Higher Nervous Activity; Male; Papio; Polyuria; Salivation; Substance P; Time Factors

1984
Plasma substance-P in neuroendocrine tumors and idiopathic flushing: the value of pentagastrin stimulation tests and the effects of somatostatin analog.
    The Journal of clinical endocrinology and metabolism, 1990, Volume: 70, Issue:6

    Topics: Adult; Aged; Carcinoid Tumor; Diagnosis, Differential; Female; Flushing; Humans; Male; Middle Aged; Octreotide; Pentagastrin; Substance P

1990
Clinical and inflammatory responses to exogenous tachykinins in allergic rhinitis.
    The American review of respiratory disease, 1991, Volume: 144, Issue:3 Pt 1

    Topics: Adult; Airway Resistance; Dose-Response Relationship, Drug; Eosinophils; Female; Flushing; Hemodynamics; Histamine; Humans; Male; Nasal Mucosa; Nasal Provocation Tests; Neurokinin B; Neutrophils; Peptide Fragments; Proteins; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Substance P; Tachykinins

1991
Flushing and plasma substance P concentration during infusion of synthetic substance P in normal man.
    Scandinavian journal of gastroenterology, 1986, Volume: 21, Issue:4

    Topics: Adult; Female; Flushing; Hemodynamics; Humans; Male; Radioimmunoassay; Substance P

1986
Tachykinins in carcinoid tumors: their use as a tumor marker and possible role in the carcinoid flush.
    The Journal of clinical endocrinology and metabolism, 1986, Volume: 63, Issue:3

    Topics: Adult; Aged; Chromatography, High Pressure Liquid; Eating; Ethanol; Female; Flushing; Humans; Hydroxyindoleacetic Acid; Male; Malignant Carcinoid Syndrome; Middle Aged; Nerve Tissue Proteins; Pentagastrin; Radioimmunoassay; Substance P; Tachykinins

1986
Vasoactive peptides and the carcinoid syndrome.
    Annals of internal medicine, 1988, Volume: 108, Issue:6

    Topics: Adult; Female; Flushing; Humans; Malignant Carcinoid Syndrome; Substance P

1988
Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system.
    Annals of neurology, 1988, Volume: 23, Issue:2

    Topics: Animals; Calcitonin Gene-Related Peptide; Cats; Electric Stimulation; Electrocoagulation; Flushing; Humans; Neuropeptides; Substance P; Trigeminal Ganglion; Trigeminal Nerve; Trigeminal Neuralgia; Vasodilator Agents

1988
Effect of a long-acting somatostatin analogue (octreotide) on circulating tachykinins and the pentagastrin-induced carcinoid flush.
    European journal of clinical pharmacology, 1989, Volume: 36, Issue:2

    Topics: Aged; Body Temperature; Carcinoid Tumor; Female; Flushing; Humans; Ileal Neoplasms; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neurokinin A; Octreotide; Pentagastrin; Radioimmunoassay; Substance P; Tachykinins

1989